Streamline Health Solutions (NASDAQ:STRM) Earns Sell Rating from Analysts at StockNews.com

Analysts at StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note issued to investors on Friday. The firm set a “sell” rating on the stock.

Streamline Health Solutions Price Performance

Shares of NASDAQ STRM opened at $3.67 on Friday. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.46 and a quick ratio of 0.46. The company has a market cap of $15.67 million, a PE ratio of -1.52 and a beta of 1.55. The stock has a fifty day moving average price of $3.73 and a 200 day moving average price of $4.10. Streamline Health Solutions has a 1-year low of $1.85 and a 1-year high of $9.75.

Streamline Health Solutions (NASDAQ:STRM) last issued its earnings results on Monday, December 16th. The company reported ($0.61) earnings per share for the quarter. Streamline Health Solutions had a negative net margin of 50.51% and a negative return on equity of 56.96%.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.